Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly versus daily leflunomide dosing in early rheumatoid arthritis
ChiCTR-TRC-09000472Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of leflunomide in rheumatoid arthritis (RA) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: DAS28 score. Started Jul 2009; status: completed.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-09000472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000472.